This company has been marked as potentially delisted and may not be actively trading. VPC Impact Acquisition (VIH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VIH vs. RPD, NABL, ZUO, SEMR, TUYA, PD, ENFN, JAMF, COUR, and PRCHShould you be buying VPC Impact Acquisition stock or one of its competitors? The main competitors of VPC Impact Acquisition include Rapid7 (RPD), N-able (NABL), Zuora (ZUO), Semrush (SEMR), Tuya (TUYA), PagerDuty (PD), Enfusion (ENFN), Jamf (JAMF), Coursera (COUR), and Porch Group (PRCH). VPC Impact Acquisition vs. Its Competitors Rapid7 N-able Zuora Semrush Tuya PagerDuty Enfusion Jamf Coursera Porch Group VPC Impact Acquisition (NASDAQ:VIH) and Rapid7 (NASDAQ:RPD) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, community ranking, media sentiment, profitability, valuation and dividends. Does the MarketBeat Community favor VIH or RPD? Rapid7 received 558 more outperform votes than VPC Impact Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformVPC Impact AcquisitionN/AN/ARapid7Outperform Votes55855.41% Underperform Votes44944.59% Do institutionals and insiders believe in VIH or RPD? 52.5% of VPC Impact Acquisition shares are held by institutional investors. Comparatively, 95.7% of Rapid7 shares are held by institutional investors. 2.6% of Rapid7 shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is VIH or RPD more profitable? Rapid7 has a net margin of 3.46% compared to VPC Impact Acquisition's net margin of 0.00%. VPC Impact Acquisition's return on equity of 0.00% beat Rapid7's return on equity.Company Net Margins Return on Equity Return on Assets VPC Impact AcquisitionN/A N/A N/A Rapid7 3.46%-130.41%4.14% Do analysts prefer VIH or RPD? Rapid7 has a consensus target price of $33.32, indicating a potential upside of 41.65%. Given Rapid7's stronger consensus rating and higher possible upside, analysts plainly believe Rapid7 is more favorable than VPC Impact Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VPC Impact Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Rapid7 1 Sell rating(s) 14 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.29 Does the media favor VIH or RPD? In the previous week, Rapid7 had 3 more articles in the media than VPC Impact Acquisition. MarketBeat recorded 3 mentions for Rapid7 and 0 mentions for VPC Impact Acquisition. Rapid7's average media sentiment score of 1.51 beat VPC Impact Acquisition's score of 0.87 indicating that Rapid7 is being referred to more favorably in the news media. Company Overall Sentiment VPC Impact Acquisition Positive Rapid7 Very Positive Which has stronger valuation & earnings, VIH or RPD? Rapid7 has higher revenue and earnings than VPC Impact Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVPC Impact AcquisitionN/AN/A-$4.86MN/AN/ARapid7$849.16M1.78$25.53M$0.3960.31 SummaryRapid7 beats VPC Impact Acquisition on 13 of the 14 factors compared between the two stocks. Get VPC Impact Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for VIH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIH vs. The Competition Export to ExcelMetricVPC Impact AcquisitionPrepackaged Software IndustryComputer SectorNASDAQ ExchangeMarket Cap$319.10M$27.79B$25.98B$8.51BDividend YieldN/A1.58%2.85%4.15%P/E RatioN/A117.2144.5019.65Price / SalesN/A15.241,698.14152.18Price / CashN/A86.0634.7434.64Price / Book15.589.456.824.59Net Income-$4.86M$440.05M$742.69M$248.23M VPC Impact Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIHVPC Impact AcquisitionN/A$12.31-5.2%N/A-30.7%$319.10MN/A0.003Gap DownRPDRapid74.1938 of 5 stars$24.34+3.1%$33.32+36.9%-37.6%$1.56B$849.16M62.412,620Positive NewsNABLN-able1.5322 of 5 stars$8.25+0.5%$9.38+13.7%-45.5%$1.56B$470.60M41.231,400News CoverageZUOZuoraN/A$10.02flat$12.00+19.8%N/A$1.54B$431.66M-20.451,390SEMRSemrush3.022 of 5 stars$10.20+1.4%$16.43+61.1%-35.3%$1.51B$396.02M127.451,170Positive NewsTUYATuya0.1258 of 5 stars$2.80-1.9%N/A+42.1%$1.51B$311.64M-93.172,420News CoverageGap DownPDPagerDuty3.9328 of 5 stars$15.88-1.2%$19.50+22.8%-31.7%$1.45B$476.13M-19.85950Analyst RevisionENFNEnfusionN/A$10.85+0.5%$12.25+12.9%+27.5%$1.40B$201.61M271.29890High Trading VolumeJAMFJamfN/A$10.60+0.3%$26.43+149.3%-39.1%$1.40B$642.90M-19.272,767COURCoursera3.2562 of 5 stars$8.64-2.4%$9.40+8.8%+23.5%$1.39B$704.87M-16.611,400Short Interest ↓Analyst RevisionPRCHPorch Group1.6985 of 5 stars$11.24+1.7%$8.89-20.9%+510.3%$1.37B$427.15M-16.061,700Insider Trade Related Companies and Tools Related Companies Rapid7 Alternatives N-able Alternatives Zuora Alternatives Semrush Alternatives Tuya Alternatives PagerDuty Alternatives Enfusion Alternatives Jamf Alternatives Coursera Alternatives Porch Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIH) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VPC Impact Acquisition Holdings Please log in to your account or sign up in order to add this asset to your watchlist. Share VPC Impact Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIH Stock Free VIH Stock Alerts